Radiotherapy market – Amethyst Group expands its operations
Ten post jest także dostępny w języku:
polski
New Amethyst radiotherapy centers have been launched in the UK and Austria. The group currently operates twelve radiotherapy centers in six countries. In total, it plans to launch twenty new centres. Some of them are already under development.
Amethyst activities in Poland and worldwide
This year, the Amethyst Group has taken a number of measures to increase treatment opportunities in Europe. In April, a third linear accelerator was installed in the clinic in Bucharest. As a result, the facility is currently able to receive 240 patients per day requiring radiotherapy treatment. Furthermore, in April Amethyst launched two centres in the UK. The centres in London and Sheffield provide non-invasive intracranial radiotherapy treatment using the GammaKnife device. In May 2020, the group launched the Amethyst Vienna Centre at Vienna’s largest private hospital, Wiener PrivatKlinik. The centre is currently able to treat 1,200 patients per year, but there is an opportunity to increase its treatment capacity with another linear accelerator.
The Amethyst Radiotherapy Centre has been operating in Poland since 2013 in close cooperation with the L. Rydygier Specialist Hospital in Krakow. Over 2.5 thousand oncological patients are treated there every year. Let us recall that a similar centre was established in the dolnoslaskie, at the Multispecialist Hospital in Zgorzelec. However, the centre has not started operations. All because the dolnoslaskie of the National Health Fund did not announce a competition for providing services in this area.
Radiotherapy market in Poland
The value of the radiotherapy market in Poland is strongly linked to the NHF contracting. Due to the fact that every second oncologic patient requires radiotherapy and the number of cancer cases will increase in the coming years, we forecast an increase in expenditure for this purpose. The assumptions of the national consultant in the field of oncological radiotherapy indicate that the number of accelerators in Poland should exceed 190 in 2025, which should also translate into higher value of the services market. At the same time, financing modern forms of treatment, such as e.g. proton teleradiotherapy, remains a big problem in the radiotherapy segment in Poland.
In total, PLN 11.2bn will be allocated for the implementation of the National Oncological Strategy in Poland in 2020. A year earlier it was PLN 10.4bn. The amount includes services provided under the so-called oncological package, clinical oncology, oncological surgery, oncological gynaecology and haematology, chemotherapy, radiotherapy and drug programmes related to oncological treatment.
